Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kripa Shankar

Showing results (41-50 of 49) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 49 results.
Metabolism: Clinical and Experimental|July 23, 2017
Curcumin-3,4-Dichloro Phenyl Pyrazole (CDPP) overcomes curcumin's low bioavailability, inhibits adipogenesis and ameliorates dyslipidemia by activating reverse cholesterol transportAbhishek Gupta, Vinay Kumar Singh, Durgesh Kumar, et al.
Journal of Lipid Research|March 21, 2014
Rohitukine inhibits in vitro adipogenesis arresting mitotic clonal expansion and improves dyslipidemia in vivoSalil Varshney, Kripa Shankar, Muheeb Beg, et al.
Obesity (Silver Spring, Md.)|May 10, 2023
Effects of thermoneutrality on food intake, body weight, and body composition in a Prader-Willi syndrome mouse modelSherri Osborne-Lawrence, Connor Lawrence, Nathan P Metzger, et al.
The Journal of Clinical Investigation|December 15, 2023
Ghrelin deletion and conditional ghrelin cell ablation increase pancreatic islet size in miceDeepali Gupta, Avi W Burstein, Dana C Schwalbe, et al.
Cell Reports|September 4, 2025
Temporal control of eating and body weight by GHSR-expressing suprachiasmatic nucleus neuronsOmprakash Singh, Sepideh Sheybani-Deloui, Soumya Kulkarni, et al.
Endocrinology|July 3, 2026
Loss of the calorie restriction response protein DEPP1 worsens diet-induced obesitySepideh Sheybani-Deloui, Kripa Shankar, Angie L Bookout, et al.
Endocrinology|November 1, 2018
Ghrelin Receptor Agonist Rescues Excess Neonatal Mortality in a Prader-Willi Syndrome Mouse ModelJuan A Rodriguez, Emily C Bruggeman, Bharath K Mani, et al.
Molecular Metabolism|May 2, 2024
A long-acting LEAP2 analog reduces hepatic steatosis and inflammation and causes marked weight loss in miceKripa Shankar, Nathan P Metzger, Connor Lawrence, et al.
Endocrinology|September 27, 2024
The LEAP2 Response to Cancer-Related Anorexia-Cachexia Syndrome in Male Mice and PatientsSalil Varshney, Kripa Shankar, Haiming L Kerr, et al.
Pageof 5

Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Metabolism: Clinical and Experimental|July 23, 2017
Curcumin-3,4-Dichloro Phenyl Pyrazole (CDPP) overcomes curcumin's low bioavailability, inhibits adipogenesis and ameliorates dyslipidemia by activating reverse cholesterol transportAbhishek Gupta, Vinay Kumar Singh, Durgesh Kumar, et al.
Journal of Lipid Research|March 21, 2014
Rohitukine inhibits in vitro adipogenesis arresting mitotic clonal expansion and improves dyslipidemia in vivoSalil Varshney, Kripa Shankar, Muheeb Beg, et al.
Obesity (Silver Spring, Md.)|May 10, 2023
Effects of thermoneutrality on food intake, body weight, and body composition in a Prader-Willi syndrome mouse modelSherri Osborne-Lawrence, Connor Lawrence, Nathan P Metzger, et al.
The Journal of Clinical Investigation|December 15, 2023
Ghrelin deletion and conditional ghrelin cell ablation increase pancreatic islet size in miceDeepali Gupta, Avi W Burstein, Dana C Schwalbe, et al.
Cell Reports|September 4, 2025
Temporal control of eating and body weight by GHSR-expressing suprachiasmatic nucleus neuronsOmprakash Singh, Sepideh Sheybani-Deloui, Soumya Kulkarni, et al.
Endocrinology|July 3, 2026
Loss of the calorie restriction response protein DEPP1 worsens diet-induced obesitySepideh Sheybani-Deloui, Kripa Shankar, Angie L Bookout, et al.
Endocrinology|November 1, 2018
Ghrelin Receptor Agonist Rescues Excess Neonatal Mortality in a Prader-Willi Syndrome Mouse ModelJuan A Rodriguez, Emily C Bruggeman, Bharath K Mani, et al.
Molecular Metabolism|May 2, 2024
A long-acting LEAP2 analog reduces hepatic steatosis and inflammation and causes marked weight loss in miceKripa Shankar, Nathan P Metzger, Connor Lawrence, et al.
Endocrinology|September 27, 2024
The LEAP2 Response to Cancer-Related Anorexia-Cachexia Syndrome in Male Mice and PatientsSalil Varshney, Kripa Shankar, Haiming L Kerr, et al.
Pageof 5